Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: Recommendations for a standardized approach

Haematologica

Volumn 94, Issue 2, 2009, Pages 264-268

  Bennett, John M ^a   Orazi, Attilio ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Abnormal localization of immature precursors; Aplastic anemia; Hypocellular myelodysplasia; Hypocellular myeloid leukemia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; BONE MARROW; CYTOGENETICS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MYELODYSPLASTIC SYNDROME;

ANEMIA, APLASTIC; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES;

EID: 59449096048     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13755     Document Type: Article

References (14)

1. Tuzuner N, Cox C, Rowe JM, Bennett JM. Hypocellular acute myeloid leukemia: the Rochester (New York) experience. Hematol Pathol 1995; 9:195-203.
2. Tuzuner N, Cox C, Rowe, JM, Watrous D, Bennett, JM. Hypocellular myelodysplastic syndrome: new proposals. Br J Haematol 1995;91:612-7.
3. Niemeyer CM, Baumann I. The myelodysplastic syndromes in children and adolescents. Seminars in Hematology 2008;45:60-70.
4. Goyal R, Qawi H, Ali I, Dar S, Dar S, Mundle S, Shetty V, et al. Biologic characteristics of patients with hypocellular myelodysplastic syndromes. Leuk Res 1999;23:357-64.
5. Young NS. Aplastic Anemia: in Young NS, editor. The Bone marrow failure syndromes. Philadelphia, Pa. WB Saunders. 2000. p. 1-46.
6. Tuzuner N, Cox C, Rowe JM, Bennett JM. Bone marrow cellularity in myeloid stem cell disorders; impact of age correction. Leuk Res 1994;18:559-64.
7. Hartsock RJ, Smith EP, Petty CS. Normal variation with aging of the hematopoietic tissue in bone marrow from anatomic iliac crest. Am J Clin Path 1965;43:326-31.
8. Tuzuner N, Bennett JM. Reference standards for bone marrow cellularity. Leuk Res 1994;18:645-7.
9. Fohlmeister I, Fischer R, Mödder B, Rister M, Schaefer HE. Aplastic anemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic and prognostic features. J Clin Pathol 1985;38:1218-24.
10. Goasguen JE, Matsuo T, Cox C, Bennett JM. Evaluation of the dysmyelopoiesis in 336 patients with De Novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival. Leukemia 1992;6:520-5.
11. De Wolf-Peeters C, Stessens R, Desmet V, Tricot G, Verwilghen RL.The histological characterization of ALIP in the myelodysplastic syndromes. Pathol Res Pract 1986;181:402-7.
12. Yue G, Hao, S, Fadare O, Baker S, Pozdnyakova O, Galili N, et al. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome. Leuk Res 2008;32:553-8.
13. Sloand EM, Wu CO, Greenberg P, Young N, Barrett J. Factors affecting response and survival in patients with myelodysplastic syndrome treated with immunosuppressive therapy. J Clin Oncol 2008;26:2505-11.
14. Koepke JA, Editor. Practical laboratory Haematology. Churchill Livingston, Philadelphia, Pa, USA. 1991. p. 134.